• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.

作者信息

Risteli J, Niemi S, Trivedi P, Mäentausta O, Mowat A P, Risteli L

机构信息

Collagen Research Unit, Biocenter, Oulu, Finland.

出版信息

Clin Chem. 1988 Apr;34(4):715-8.

PMID:3359606
Abstract

This is an equilibrium-type radioimmunoassay for the amino-terminal propeptide of type III procollagen (PIIINP), which overcomes the problem of nonparallelism between the standard and human serum samples encountered with earlier assays. Proper selection of antiserum and reaction conditions diminishes interference from degradation products of the propeptide in serum. Because a rapid solid-phase-bound second-antibody step is included, the assay takes only 3 h. The intra-assay and the interassay CVs are both about 5%. In infants and children the concentration of PIIINP in serum closely parallels the growth-velocity curve. For 88 presumably healthy adults, the PIIINP concentration was 1.7-4.2 micrograms/L, about a third that measured with the previously available commercial assay. This is because of lack of inhibition by small Col 1 domain-related degradation products.

摘要

相似文献

1
Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen.
Clin Chem. 1988 Apr;34(4):715-8.
2
Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.用于测量犬血清和支气管肺泡灌洗液体中III型前胶原氨基端前肽的放射免疫分析方法的分析、生理学及临床验证。
Am J Vet Res. 2006 May;67(5):749-55. doi: 10.2460/ajvr.67.5.749.
3
Radioimmunoassays for type III procollagen amino-terminal peptides in humans.人类III型前胶原氨基端肽的放射免疫测定法。
Clin Chem. 1985 Aug;31(8):1301-4.
4
A radioimmunoassay for the N-terminal propeptide of rat procollagen type III. Application to the study of the uptake of the N-terminal propeptide of procollagen type III in isolated perfused rat liver.大鼠Ⅲ型前胶原N端前肽的放射免疫测定法。应用于离体灌注大鼠肝脏中Ⅲ型前胶原N端前肽摄取的研究。
Matrix. 1993 Sep;13(5):381-7. doi: 10.1016/s0934-8832(11)80043-0.
5
Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis.应用接受者操作特征分析比较慢性丙型肝炎中III型前胶原N端前肽的检测方法
Eur J Gastroenterol Hepatol. 1999 Aug;11(8):827-31. doi: 10.1097/00042737-199908000-00003.
6
Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.人I型前胶原羧基末端前肽的放射免疫测定
Clin Chem. 1990 Jul;36(7):1328-32.
7
Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments.采用抗体Fab片段放射免疫分析法对血清和尿液中的III型前胶原氨基端肽进行分析。
Coll Relat Res. 1983 Sep;3(5):371-9. doi: 10.1016/s0174-173x(83)80018-1.
8
Laminin and aminoterminal propeptide of type III procollagen in seminal plasma from fertile and vasectomized men.来自生育能力正常和输精管结扎男性的精浆中的层粘连蛋白和III型前胶原氨基末端前肽。
Andrologia. 1993 Jul-Aug;25(4):217-21. doi: 10.1111/j.1439-0272.1993.tb02712.x.
9
Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.生长速度、生长激素治疗以及III型前胶原氨基端前肽的血清浓度。
J Pediatr. 1989 Feb;114(2):225-30. doi: 10.1016/s0022-3476(89)80787-5.
10
The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects.I型前胶原氨基端前肽:一种商用放射免疫分析试剂盒的评估及健康受试者的检测值
Clin Biochem. 1997 Feb;30(1):35-40. doi: 10.1016/s0009-9120(96)00134-8.

引用本文的文献

1
Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.III型前胶原氨基端前肽和胰岛素样生长因子I作为生长激素给药的生物标志物。
Drug Test Anal. 2022 May;14(5):808-819. doi: 10.1002/dta.3155. Epub 2021 Sep 6.
2
Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.III 型胶原(COL3A1):基因和蛋白质结构、组织分布及相关疾病。
Gene. 2019 Jul 30;707:151-171. doi: 10.1016/j.gene.2019.05.003. Epub 2019 May 7.
3
Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study.
健康活体肾供体心肌的长期结构和功能适应性:一项初步研究。
PLoS One. 2015 Nov 10;10(11):e0142103. doi: 10.1371/journal.pone.0142103. eCollection 2015.
4
Serum PINP, PIIINP, galectin-3, and ST2 as surrogates of myocardial fibrosis and echocardiographic left venticular diastolic filling properties.血清PINP、PIIINP、半乳糖凝集素-3和ST2作为心肌纤维化及超声心动图左心室舒张期充盈特性的替代指标。
Front Physiol. 2015 Jul 13;6:200. doi: 10.3389/fphys.2015.00200. eCollection 2015.
5
Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study.尿胶原片段与慢性肾脏病进展——心血管健康研究
J Am Soc Nephrol. 2015 Oct;26(10):2494-503. doi: 10.1681/ASN.2014070696. Epub 2015 Feb 5.
6
Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS).循环纤维化生物标志物与心房颤动风险:心血管健康研究(CHS)。
Am Heart J. 2014 May;167(5):723-8.e2. doi: 10.1016/j.ahj.2014.01.010. Epub 2014 Feb 26.
7
Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.心肌微损伤通过肌钙蛋白 T 测量,预测 65 岁及以上心力衰竭成年人的胶原代谢。
Circ Heart Fail. 2012 Jul 1;5(4):406-13. doi: 10.1161/CIRCHEARTFAILURE.111.965327. Epub 2012 Jun 8.
8
The relationship between serum markers of collagen turnover and cardiovascular outcome in the elderly: the Cardiovascular Health Study.老年人群血清胶原转换标志物与心血管结局的关系:心血管健康研究。
Circ Heart Fail. 2011 Nov;4(6):733-9. doi: 10.1161/CIRCHEARTFAILURE.111.962027. Epub 2011 Sep 7.
9
Identification of serum biomarkers for aging and anabolic response.鉴定与衰老和合成代谢反应相关的血清生物标志物。
Immun Ageing. 2011 Jun 20;8(1):5. doi: 10.1186/1742-4933-8-5.
10
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.类风湿关节炎持续关节损伤的生化标志物——当前和未来的应用、局限性和机遇。
Arthritis Res Ther. 2011 Apr 28;13(2):215. doi: 10.1186/ar3280.